485
Views
4
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for hyperlipidaemia: an update

, , MD, & , MD FASA FRSH

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Aris P Agouridis, Michael S Kostapanos & Moses S Elisaf. (2015) Statins and their increased risk of inducing diabetes. Expert Opinion on Drug Safety 14:12, pages 1835-1844.
Read now
Aris P Agouridis, Devaki R Nair & Dimitri P Mikhailidis. (2015) Strategies to overcome statin intolerance. Expert Opinion on Drug Metabolism & Toxicology 11:6, pages 851-855.
Read now

Articles from other publishers (2)

Ke Su, Bingbao Chen, Xiaoting Tu, Luxin Ye, Xiaojie Lu, Zheng Yu, Xianqin Wang & Xuezhi Yang. (2021) Metabolic Changes in Hyperlipidemic Rats After The Administration of Xuezhikang. Current Pharmaceutical Analysis 17:6, pages 702-709.
Crossref
Haohai Huang, Ying Zou, Honggang Chi & Dan Liao. (2018) Lipid-Modifying Effects of Chitosan Supplementation in Humans: A Pooled Analysis with Trial Sequential Analysis. Molecular Nutrition & Food Research 62:8, pages 1700842.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.